Trillium Therapeutics Inc. Soared

Thu 23 Jan 20 at 05:30 PM
Trillium Therapeutics Inc. Soared

Trillium Therapeutics Inc. (TRIL:NASDAQ) shot up at $4.22, representing a gain of 29.2%. On Wed 22 Jan 20, TRIL:NASDAQ touched a New 2-Week High of $3.27. The stock got featured on our News Catalysts scanner on Thu 23 Jan 20 at 09:36 AM in the 'PUBLIC OFFERING' category. From Tue 31 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Share